Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 31,447 | 12,537 | 10,797 | 10,486 | 9,598 |
| Cost of Goods | 2,021 | 2,475 | 1,140 | 1,831 | 1,461 |
| Gross Profit | 29,426 | 10,062 | 9,657 | 8,655 | 8,137 |
| Operating Expenses | 30,601 | 36,554 | 49,742 | 37,181 | 44,356 |
| Operating Income | -1,154 | -26,017 | -39,945 | -27,695 | -35,758 |
| Other Income | 2,311 | -1,509 | -1,186 | -373 | -1,135 |
| Pre-tax Income | 1,157 | -27,526 | -41,131 | -28,068 | -36,893 |
| Net Income Continuous | 1,157 | -27,526 | -41,131 | -28,068 | -36,893 |
| Net Income | $1,157 | $-27,526 | $-41,131 | $-28,068 | $-36,893 |
| EPS Basic Total Ops | 0.02 | -0.63 | -0.94 | -0.64 | -0.89 |
| EPS Basic Continuous Ops | 0.03 | -0.63 | -0.94 | -0.64 | -0.89 |
| EPS Diluted Total Ops | 0.02 | -0.63 | -0.94 | -0.64 | -0.84 |
| EPS Diluted Continuous Ops | 0.03 | -0.63 | -0.94 | -0.64 | -0.84 |
| EBITDA(a) | $-924 | $-25,791 | $-39,757 | $-27,500 | $-35,467 |